ACARIX Share Price Performance
SEK 0.32
0.02 (7.51%)
Price SEK 0.32
Share PriceSEK 0.32
We Think Acarix (STO:ACARIX) Can Afford To Drive Business Growth
Aug 01
Acarix AB (publ) Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 5 Fair Values set on narratives written by author
ACARIX Community Narratives
There are no narratives available yet.
Acarix AB (publ) Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Nov 06, 2025
- Earnings per share (EPS)
- -0.055
- Gross Margin
- 87.49%
- Net Profit Margin
- -1,106.72%
- Debt/Equity Ratio
- 0%
Acarix AB (publ) Competitors
Snowflake Analysis
About ACARIX
- Founded
- 2009
- Employees
- 8
- CEO
- WebsiteView website
Acarix AB (publ), a medical device company, develops solutions for rapid AI-based coronary artery disease rule-out. The company offers CADScor System, a point-of-care diagnostic aid that uses sensitive acoustics and advanced computational processing to analyze the patient's coronary blood flow. It sells its products in the Nordic countries, the United Kingdom, Germany, Switzerland, Austria, Mauritius, and the United States. The company was founded in 2009 and is headquartered in Malmö, Sweden.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Swedish Market Performance
- 7 Days: 2.5%
- 3 Months: 3.2%
- 1 Year: -1.0%
- Year to Date: 3.1%
The market has climbed 2.7% in the last 7 days, lead by the Industrials sector with a gain of 3.2%. In the last 12 months, the market has been flat. As for the next few years, earnings are expected to grow by 16% per annum. Market details ›